World's Best Scientists 2026 revealed!
Mark Hyman Rapaport

Mark Hyman Rapaport

D-Index & Metrics

Medicine

D-Index
76
Citations
28004
World Ranking
18651
National Ranking
9290

Overview

Mark Hyman Rapaport is affiliated with Emory University in the United States. Their research intersects multiple fields including Neuroscience, Medicine, and Biochemistry, Genetics and Molecular Biology, with significant contributions in Genetics, Biological Psychiatry, and Psychiatry and Mental Health as subfields.

The scientist's main research focuses encompass a variety of topics related to brain and mental health, including:

  • Tryptophan and brain disorders
  • Stress Responses and Cortisol
  • Genetic Associations and Epidemiology
  • Psychosomatic Disorders and Their Treatments
  • Genomics and Rare Diseases
  • Vagus Nerve Stimulation Research
  • Heart Rate Variability and Autonomic Control

Mark Hyman Rapaport has contributed to several recent papers that have appeared in a range of scientific journals. These include:

  • "Rare coding variants in ten genes confer substantial risk for schizophrenia," published in 2022 in Nature
  • "Diet, Stress and Mental Health," published in 2020 in Nutrients
  • "Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits," published in 2020 in Frontiers in Psychiatry
  • "Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans," published in 2020 in Schizophrenia Bulletin
  • "Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders," published in 2020 in Journal of Personalized Medicine

The frequent co-authors collaborating with Rapaport include:

  • Becky Kinkead
  • Boadie W. Dunlop
  • Pamela J. Schettler
  • P.F. Buckley
  • Dolores Malaspina

Rapaport's work is often published in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Clinical Psychiatry
  • CNS Spectrums
  • Brain Behavior & Immunity - Health
  • Nature

Best Publications

  • Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

    Herbert Y. Meltzer;Larry Alphs;Alan I. Green;A. Carlo Altamura

  • Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

    Niamh Mullins;Andreas J. Forstner;Andreas J. Forstner;Andreas J. Forstner;Kevin S. O'Connell;Kevin S. O'Connell;Brandon Coombes

  • A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

    D R Goldsmith;M H Rapaport;B J Miller

  • Quality-of-life impairment in depressive and anxiety disorders.

    Mark Hyman Rapaport;Cathryn Clary;Rana Fayyad;Jean Endicott

  • Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

    A. John Rush;Lauren B. Marangell;Harold A. Sackeim;Mark S. George;Mark S. George

  • Socioeconomic Burden of Subsyndromal Depressive Symptoms and Major Depression in a Sample of the General Population

    Lewis L. Judd;Martin P. Paulus;Kenneth B. Wells;Mark H. Rapaport

  • Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.

    Barbara L Brody;Anthony C Gamst;Rebecca A Williams;Amanda R Smith

  • Subsyndromal symptomatic depression: a new mood disorder?

    Lewis L. Judd;Mark Hyman Rapaport;Martin P. Paulus;John L. Brown

  • TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament.

    Hagop S. Akiskal;Hagop S. Akiskal;Mauro V. Mendlowicz;Mauro V. Mendlowicz;Girardin Jean-Louis;Mark H. Rapaport;Mark H. Rapaport

  • Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.

    David Pickar;Richard R. Owen;Robert E. Litman;P. Eric Konicki

  • A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22

    John R. Kelsoe;M. Anne Spence;Erika Loetscher;Montserrat Foguet

  • Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study

    Mark Hyman Rapaport;Andrew A Nierenberg;Pamela J. Schettler;Becky Kinkead

  • Quality of life: the ultimate outcome measure of interventions in major depressive disorder.

    Waguih William IsHak;Jared Matt Greenberg;Konstantin Balayan;Nina Kapitanski

  • C-reactive protein levels in schizophrenia: a review and meta-analysis.

    Brian J. Miller;Nick Culpepper;Mark H. Rapaport

  • Clinical and Physiological Consequences of Rapid Tryptophan Depletion

    Polly Moore;Polly Moore;Hans-Peter Landolt;Erich Seifritz;Erich Seifritz;Camellia Clark

  • Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment

    Mark Hyman Rapaport;Lewis L Judd

  • Diet, Stress and Mental Health.

    J Douglas Bremner;J Douglas Bremner;Kasra Moazzami;Matthew T Wittbrodt;Jonathon A Nye

  • A descriptive analysis of minor depression.

    Mark Hyman Rapaport;Lewis L. Judd;Pamela J. Schettler;Kimberly Ann Yonkers

  • Elevated levels of soluble interleukin 2 receptors in schizophrenia.

    Mark Hyman Rapaport;Cathy G. McAllister;David Pickar;David L. Nelson

  • Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.

    Lev Gertsik;Russell E. Poland;Catherine Bresee;Mark Hyman Rapaport

Frequent Co-Authors

John R. Kelsoe
John R. Kelsoe University of California, San Diego
J. Christian Gillin
J. Christian Gillin University of California, San Diego
Peter F. Buckley
Peter F. Buckley University of Tennessee Health Science Center
David Mischoulon
David Mischoulon Harvard University
Steven A. McCarroll
Steven A. McCarroll Harvard University
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Boadie W. Dunlop
Boadie W. Dunlop Emory University
Mauro V. Mendlowicz
Mauro V. Mendlowicz Federal University of Rio de Janeiro
Dolores Malaspina
Dolores Malaspina Icahn School of Medicine at Mount Sinai
David Pickar
David Pickar National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA can lead to diverse and rewarding career options beyond the traditional MD. Many healthcare professionals are choosing alternative routes, such as administration, nursing, or pharmacy, made even more accessible through online education.

For those interested in leadership roles, cheapest online mha programs offer a pathway to overseeing hospital operations and improving healthcare systems. Nurses seeking top credentials may consider the best online bsn to dnp programs, which provide advanced practice and research skills.

If pharmacy interests you, a 3-year online pharmd can quickly prepare students for clinical or consulting roles. Meanwhile, those inclined toward health data and technology can achieve management positions through rhia certification programs online.

These online degrees offer flexibility and affordability for students aiming to advance or pivot in the healthcare field, helping them meet the evolving demands of modern medicine.

Best Scientists Citing Mark Hyman Rapaport

Trending Scientists

Recently Published Articles